HIV positive pregnant women receiving antiretrovirals, using in Burkina Faso
Burkina Faso: HIV positive pregnant women receiving antiretrovirals, using was 54.0% in 2011. ◆ Volatile
HIV positive pregnant women receiving antiretrovirals, using in Burkina Faso, 2004–2011
Source: http://data.unaids.org/pub/GlobalReport/2008/. Measured in %; high estimate.
Analysis
The most recent figure for hiv positive pregnant women receiving antiretrovirals, using in Burkina Faso is 54.0%, measured in 2011.
That represents a change of down 10.0% on the previous year and up 800.0% over ten years.
Burkina Faso ranks 24th of 38 countries on this measure, in the middle of the range.
HIV positive pregnant women receiving antiretrovirals, using in Burkina Faso, year by year
| Year | %; high estimate | Change |
|---|---|---|
| 2004 | 6.0% | — |
| 2005 | 13.0% | +116.7% |
| 2006 | 23.0% | +76.9% |
| 2007 | 22.0% | -4.3% |
| 2009 | 60.0% | +172.7% |
| 2011 | 54.0% | -10.0% |
Burkina Faso compared with similar countries
- Burkina Faso's 54.0% is below the median for Sub-Saharan Africa, which is 62.0%, 87% of the median. (38 countries reporting)
- Burkina Faso's 54.0% is above the median for low income countries, which is 54.0%, 1.0× the median. (17 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 24.8% | 6.0% | 60.0% | 5 |
| 2010s | 54.0% | 54.0% | 54.0% | 1 |
Countries ranked near Burkina Faso
More health data for Burkina Faso
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8925 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,142 deaths per 1,000 people (2090)
- Number of infants who die before age 1 13,085 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 4 (2025)
- Population ages 00-04, female, annual growth rate 0.8681 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0693 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.7133 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is hiv positive pregnant women receiving antiretrovirals, using in Burkina Faso?
- Hiv positive pregnant women receiving antiretrovirals, using in Burkina Faso was 54.0% in 2011, according to http://data.unaids.org/pub/GlobalReport/2008/.
- What is the highest hiv positive pregnant women receiving antiretrovirals, using recorded in Burkina Faso?
- The highest recorded value was 60.0% in 2009.
- What is the lowest hiv positive pregnant women receiving antiretrovirals, using recorded in Burkina Faso?
- The lowest recorded value was 6.0% in 2004.
- How does Burkina Faso rank for hiv positive pregnant women receiving antiretrovirals, using?
- Burkina Faso ranks 24th out of 38 countries with data for 2011.
- Is hiv positive pregnant women receiving antiretrovirals, using rising or falling in Burkina Faso?
- Over the last ten years it is up 800.0%. The long-run trend across the full record is volatile.
- Where does this Burkina Faso data come from?
- The figures come from http://data.unaids.org/pub/GlobalReport/2008/, published as part of HIV positive pregnant women receiving antiretrovirals, using WHO/UNAIDS methodology (%; high estimate). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of HIV-infected pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission. Numerator: Number of HIV-infected pregnant women who received antiretrovirals during the last 12 months to reduce mother-to-child transmission. Denominator: Estimated number of HIV-infected pregnant women in the last 12 months. Ranges are presented for countries with low and concentrated epidemics. The purpose of this indicator is to assess progress in preventing vertical transmission of HIV. All data reflect values representing 12 month period ending December 2007 which have been reconciled between reporting country and UNAIDS/WHO/UNICEF, unless otherwise noted. All analysis of this indicator, including quoted country figures, reflect numerators which have gone through a tri agency reconciliation (UNAIDS/WHO/UNICEF) process and denominators which have been estimated directly from the UNAIDS/WHO Reference group on Estimates, Modelling and Projections methodology (Spectrum). The reconciliation process ensured all agencies reported the same country endorsed figure which was the most recent and met the definition of HIV-infected women receiving antiretroviral drugs over the last 12 months, and thus reflect a full year. Every effort was made in cases of discrepancy across the three agencies to obtain approval from the country on a final indicator value.